The nation of Zimbabwe has rejected a significant American health deal worth $367m (272 million pounds) spanning five years because of the United States' insistence on confidential data.
This rejection became public following a internal memorandum dated December was leaked, which showed President Emmerson Mnangagwa felt the arrangement was "skewed".
An official spokesperson has since stated that the US was requesting health data for scientific study and profit while was not willing to guarantee the benefits from any future vaccines.
"We are forced to start the challenging and unfortunate process of scaling back our support in Zimbabwe," said US ambassador to Zimbabwe Pamela Tremont publicly.
Her embassy indicated the United States had furnished over $1.9bn as health assistance to Zimbabwe during the past twenty years.
A doctors' association in Zimbabwe has urged continued dialogue to reach a deal suitable to all parties so the country's vital HIV treatment initiative can continue.
Broader Background
Zimbabwe's decision follows a similar case in Kenya, where a high court halted a similar deal with the US after concerns were raised about the safety of Kenyans' medical information.
Since resuming office last year, US President Donald Trump has drastically cut foreign aid and shut down the US Agency for International Development (USAID).
The agency had managed assistance for the American government, but Trump stated its spending was "inefficient" and his administration was seeking direct bilateral agreements to boost openness and accountability.
According to reports, 16 African countries have so far agreed to similar agreements, representing more than $18.3bn of fresh investment.
Specifics of the Rejected Agreement
This assistance for Zimbabwe was intended to gone towards "HIV/Aids treatment and prevention, TB, malaria, maternal and child health, and preparing for epidemics".
"We believe this cooperation would have delivered extraordinary advantages for the people of Zimbabwe, particularly the 1.2 million men, women and children presently on antiretroviral therapy through American-funded initiatives," Tremont commented.
However, government spokesperson Nick Mangwana said the arrangement was "unequal".
"Our nation was requested to surrender its genetic material and health information over an extended period, without any equivalent promise of benefiting from any scientific breakthroughs – such as vaccines, diagnostics, or treatments – that could be developed from that shared data," his statement read.
"In essence, our country would supply the raw materials for medical research without any certainty that the final treatments would be available to our population should a new health crisis arise."
Sovereignty and Global Health
Mangwana further said that the American exit from the global health body and its pursuit of one-on-one health agreements were undermining structures previously set up via the global health agency.
Mangwana gave as an example its Pathogen Access and Benefit Sharing framework created to deal with potential global health emergencies.
"This mechanism is intended to guarantee that when a nation provides its samples, the resulting advantages – such as medicines and cures – are shared equitably, not monopolised solely by those with the resources to develop them."
These objections over the US deal "should not be misconstrued as hostility towards the US," Mangwana stressed.
"We are open to ongoing dialogue with our US partners on how subsequent co-operation might be designed in a way that honours the independence and interests of each country."
Health Experts Response
A leading public health body said it understood the official position, but suggested that negotiations must proceed considering a large portion of the nation's Aids initiatives depended on international support.
"Where specific concerns exist, including those involving data governance or agreement terms, these can often be resolved through technical clarification and negotiated safeguards," it said.
The situation underscores the ongoing debate between receiving vital foreign assistance and protecting national sovereignty in an increasingly interconnected world.